PharmaSGP Holding SE (PSG) — Cash Flow Quality Index
PharmaSGP Holding SE (PSG) has a Cash Flow Quality Index of 0.89x as of March 2025. Operating cash flow of €4.22 Million is below net income of €4.73 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PharmaSGP Holding SE (PSG) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PharmaSGP Holding SE Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for PharmaSGP Holding SE across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PharmaSGP Holding SE investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for PharmaSGP Holding SE (2014–2024)
Year-by-year earnings quality comparison for PharmaSGP Holding SE. For live market cap and the full company financial profile, see market cap of PharmaSGP Holding SE.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.27x | €24.88 Million | €19.54 Million | ▼ -21.6% |
| 2023 | 1.62x | €26.64 Million | €16.40 Million | ▼ -21.4% |
| 2022 | 2.07x | €24.71 Million | €11.95 Million | ▲ +80.6% |
| 2021 | 1.14x | €12.24 Million | €10.69 Million | ▼ -21.2% |
| 2020 | 1.45x | €15.46 Million | €10.64 Million | ▲ +37.7% |
| 2019 | 1.06x | €17.63 Million | €16.71 Million | ▲ +84.5% |
| 2018 | 0.57x | €8.43 Million | €14.73 Million | ▼ -52.7% |
| 2017 | 1.21x | €14.25 Million | €11.78 Million | ▲ +76.7% |
| 2016 | 0.68x | €3.55 Million | €5.18 Million | ▼ -55.2% |
| 2015 | 1.53x | €10.59 Million | €6.93 Million | ▼ -24.4% |
| 2014 | 2.02x | €5.41 Million | €2.68 Million | — |